Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia

Journal of Experimental Medicine

Volumn 187, Issue 11, 1998, Pages 1921-1926

  Sparer, Tim E ^a   Matthews, Stephen ^a   Hussell, Tracy ^a   Rae, Aaron J ^a   Garcia Barreno, Blanca ^b   Melero, Jose A ^b   Openshaw, Peter J M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Eosinophilia; G protein; Respiratory syncytial virus; T helper cell; Vaccine

Indexed keywords

ANIMAL CELL; ARTICLE; CELL PROTECTION; IMMUNE RESPONSE; INFECTION RISK; LOEFFLER PNEUMONIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SCAR FORMATION; SENSITIZATION; VIRUS INFECTION;

ANIMALS; CHROMOSOME MAPPING; EOSINOPHILIA; FEMALE; HN PROTEIN; HUMANS; LUNG; MICE; MICE, INBRED BALB C; MUTAGENESIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; TUMOR CELLS, CULTURED; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRAL VACCINES; WEIGHT LOSS;

EID: 0032101551     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.11.1921     Document Type: Article

References (35)

1. Anderson, L.J., and C.A. Heilman. 1995. Protective and disease-enhancing immune responses to respiratory syncytial virus. J. Infect. Dis. 171:1-7.
2. Openshaw, P.J.M. 1995. Immunopathological mechanisms in respiratory syncytial virus disease. Semin. Immunopathol. 17: 187-201.
3. Sigurs, N., R. Bjarnason, F. Sigurbergsson, B. Kjellman, and B. Bjorksten. 1995. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 95:500-505.
4. Kim, H.W., J.G. Canchola, C.D. Brandt, G. Pyles, R.M. Chanock, K. Jensen, and R.H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
5. Fulginiti, V.A., J.J. Eller, O.F. Sieber, J.W. Joyner, M. Minamitani, and G. Meiklejohn. 1969. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines: an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89:436-448.
6. Kapikian, A.Z., R.H. Mitchell, R.M. Chanock, R.A. Shvedoff, and C.E. Stewart. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-421.
7. Chin, J., R.L. Magoffin, L.A. Shearer, J.H. Schieble, and E.H. Lennette. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89:449-463.
8. Openshaw, P.J.M., S.L. Clarke, and F.M. Record. 1992. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 4:493-500.
9. Levine, S., R. Klaiber Franco, and P.R. Paradiso. 1987. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 68:2521-2524.
10. Alwan, W.H., W.J. Kozlowska, and P.J.M. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:81-89.
11. Srikiatkhachorn, A. and T.J. Braciale. 1997. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection J. Virol. 71:678-685.
12. Graham, B.S., L.A. Bunton, P.F. Wright, and D.T. Karzon. 1991. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice J. Clin. Invest. 88:1026-1033.
13. Hussell, T., C.J. Baldwin, A. O'Garra, and P.J.M. Openshaw. 1997. CD4+ T-cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27:3341-3349.
14. Garcia Barreno, B., A. Portela, T. Delgado, J.A. Lopez, and J.A. Melero. 1990. Frame shift mutations as a novel mechanism for the generation of neutralization resistant mutants of human respiratory syncytial virus. EMBO (Eur. Mol. Biol. Organ.) J. 9:4181-4187.
15. Arbiza, J., G. Taylor, J.A. Lopez, J. Furze, S. Wyld, P. Whyte, J. Stott, G. Wertz, W. Sullender, M. Trudel, and J.A. Melero. 1992. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the F glycoprotein of human respiratory syncytial virus. J. Gen. Virol. 73:2225-2234.
16. Simard, C., F. Nadon, C. Sèguin, and M. Trudel. 1995. Evidence that the amino acid region 124-203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infection. Antiviral Res. 28:303-315.
17. Stott, E.J., L.A. Ball, K.K. Young, J. Furze, and G.W. Wertz. 1986. Human respiratory syncytial virus glycoprotein G expressed from recombinant vaccinia virus vector protects mice against live virus challenge. J. Virol. 60:607-613.
18. Wertz, G.W., E.J. Stott, K.K.J. Young, K. Anderson, and L.A. Ball. 1987. Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. J. Virol. 61:293-301.
19. Hussell, T., L.C. Spender, A. Georgiou, A. O'Garra, and P.J.M Openshaw. 1996. Th1 and Th2 cytokine induction in pulmonary T-cells during infection with respiratory syncytial virus. J. Gen. Virol. 77:2447-2455.
20. Tebbey, P.W., and G.E. Hancock. 1997. Characterization of immune responses to the attachment (G) protein of respiratory syncytial virus in inbred mice. 10th International Conference on Negative Strand Viruses. A152 (Abstr.).
21. Rammensee, H.G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:178-228.
22. + T cell epitope on nucleocapsid protein which induces different T-helper cell subsets. Virology. 225:339-346.
23. Milich, D.R., D.L. Peterson, F. Schodel, J.E. Jones, and J.L. Hughes. 1995. Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J. Virol. 69:2776-2785.
24. Haraguchi, S., R.A. Good, M.J. Yarish, G.J. Cianciolo, and N.K. Day. 1995. Differential modulation of Th1-and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc. Natl. Acad. Sci. USA. 92:3611-3615. (See published erratum 92:9009.)
25. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181: 1569-1574.
26. Alwan, W.H., F.M. Record, and P.J.M. Openshaw. 1993. Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. J. Immunol. 150:5211-5218.
27. Graham, B.S., G.S. Henderson, Y.W. Tang, X. Lu, K.M. Neuzil, and D.G. Colley. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040.
28. Collins, P.D., S. Marleau, D.A. Griffiths Johnson, P.J. Jose, and T.J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169-1174.
29. Saito, T., R.W. Deskin, A. Casola, H. Haeberle, B. Olszewska, P.B. Ernst, R. Alam, P.L. Ogra, and R. Garofalo. 1997. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J. Infect. Dis. 175:497-504.
30. Hussell, T., U. Khan, and P.J.M. Openshaw. 1997. IL-12 treatment attenuates Th2 and B cell responses but does not improve vaccine-enhanced lung illness. J. Immunol. 159: 328-334.
31. Orange, J.S., T.P. Salazar Mather, S.M. Opal, R.L. Spencer, A.H. Miller, B.S. McEwen, and C.A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901-914.
32. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186:421-432.
33. Pemberton, R.M., M.J. Cannon, P.J.M. Openshaw, L.A. Ball, G.A. Wertz, and B.A. Askonas. 1987. Cytotoxic T-cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. J. Gen. Virol. 68:2177-2182.
34. Alwan, W.H. and P.J.M. Openshaw. 1993. Distinct patterns of T and B cell immunity to respiratory syncytial virus induced by individual proteins. Vaccine. 11:431-437.
35. + cells. Clin. Exp. Immunol. 88:527-536.